Get the Stockscreener App
9.08
4.62%
-0.44
After Hours:
9.08
Delcath Systems Inc stock is traded at $9.08, with a volume of 1.75M.
It is down -4.62% in the last 24 hours and down -18.20% over the past month.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
See More
Previous Close:
$9.52
Open:
$9.08
24h Volume:
1.75M
Relative Volume:
2.04
Market Cap:
$317.63M
Revenue:
$2.07M
Net Income/Loss:
$-47.68M
P/E Ratio:
-3.2199
EPS:
-2.82
Net Cash Flow:
$-31.31M
1W Performance:
-10.54%
1M Performance:
-18.20%
6M Performance:
-26.77%
1Y Performance:
-15.69%
1-Day Range:
$8.70
$9.66
1-Week Range:
$8.70
$10.13
52-Week Range:
$8.70
$18.23
Delcath Systems Inc Stock (DCTH) Company Profile
Name
Delcath Systems Inc
Sector
Industry
Phone
(518) 743-8892
Address
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Compare DCTH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
9.08 | 333.02M | 2.07M | -47.68M | -31.31M | -2.82 |
|
ABT
Abbott Laboratories
|
125.80 | 215.34B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.84 | 146.15B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
362.61 | 136.97B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.42 | 115.69B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
84.15 | 48.77B | 5.88B | 1.34B | 577.90M | 2.3455 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-28-24 | Initiated | Craig Hallum | Buy |
| May-14-24 | Initiated | Stephens | Overweight |
| Jul-26-22 | Resumed | Canaccord Genuity | Buy |
| Dec-10-21 | Initiated | H.C. Wainwright | Buy |
| Mar-09-21 | Initiated | Canaccord Genuity | Buy |
| Jan-05-21 | Initiated | BTIG Research | Buy |
| Jun-01-20 | Initiated | Laidlaw | Buy |
View All
Delcath Systems Inc Stock (DCTH) Latest News
Should Delcath Systems' Transition to Year-to-Date Profitability Prompt a Rethink for DCTH Investors? - Yahoo Finance
Delcath Systems Inc (DCTH) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Delcath’s Revenue Misses But HEPZATO Sales Power Optimism - Finimize
BTIG Reiterates Buy Rating for Delcath Systems (DCTH) with $23 P - GuruFocus
Is Delcath Systems’ First Nine-Month Net Profit Reshaping the Investment Case for DCTH? - simplywall.st
Delcath Systems, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Earnings call transcript: Delcath Systems Q3 2025 results disappoint investors By Investing.com - Investing.com
Delcath Systems, Inc. (DCTH) Q3 Earnings Match Estimates - Yahoo! Finance Canada
Will Delcath Systems Inc. benefit from macro trendsDay Trade & Capital Protection Trade Alerts - newser.com
Delcath Systems Inc Reports Q3 2025 Revenue of $20.6M, Slightly Missing Estimates; Net Income at $0.8M - GuruFocus
Delcath Systems Inc. Reveals Retreat In Q3 Bottom Line, But Beats Estimates - Nasdaq
Cancer therapy developer Delcath Q3 revenue misses estimates - MarketScreener
Delcath Systems Reports Third Quarter 2025 Results and Business Highlights - Yahoo Finance
Can volume confirm reversal in Delcath Systems Inc.July 2025 Closing Moves & Safe Capital Growth Stock Tips - newser.com
Is Delcath Systems Inc. showing signs of accumulation2025 Sector Review & Daily Chart Pattern Signal Reports - newser.com
Is it time to cut losses on Delcath Systems Inc.Weekly Risk Summary & Weekly Setup with High ROI Potential - newser.com
Will Delcath Systems Inc. (DV3R) stock issue positive guidance2025 Earnings Impact & Consistent Return Investment Signals - newser.com
Order flow analysis tools used on Delcath Systems Inc.July 2025 Sector Moves & Consistent Profit Trade Alerts - newser.com
Forecasting Delcath Systems Inc. price range with options dataJuly 2025 Analyst Calls & Free Long-Term Investment Growth Plans - newser.com
What insider purchases suggest about Delcath Systems Inc. (DV3R) stockJuly 2025 Pullbacks & Daily Stock Trend Watchlist - newser.com
Real time breakdown of Delcath Systems Inc. stock performanceTrade Exit Report & Advanced Swing Trade Entry Plans - newser.com
Is Delcath Systems Inc. stock bottoming outWeekly Investment Recap & AI Based Buy and Sell Signals - newser.com
Will Delcath Systems Inc. stock reach all time highs in 2025Wall Street Watch & Growth-Oriented Investment Plans - newser.com
Delcath Systems Inc DV3R Stock Analysis and ForecastVolatility Trading Techniques & Register for the Next Free Workshop - earlytimes.in
Is Delcath Systems Inc. (DV3R) stock a contrarian opportunityJuly 2025 Update & Fast Gain Stock Trading Tips - newser.com
Evaluating Delcath Systems Inc. with trendline analysisWeekly Trade Recap & Fast Entry Momentum Trade Alerts - newser.com
Is Delcath Systems Inc. (DV3R) stock a buy before earnings resultsRate Hike & High Return Stock Watch Alerts - newser.com
Volatility clustering patterns for Delcath Systems Inc.2025 Winners & Losers & Low Risk Entry Point Guides - newser.com
Published on: 2025-10-30 23:43:51 - newser.com
Delcath Systems (DCTH) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Delcath Systems, Inc. (NASDAQ:DCTH) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Delcath Systems Inc Stock (DCTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.47%
0.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):